Lung-on-Chip Technology $1.5B OOC Market by 2030 COVID-19 Drug Discovery 87% Toxicity Prediction COPD + Asthma Models 35% CAGR Growth Air-Liquid Interface Lung-on-Chip Technology $1.5B OOC Market by 2030 COVID-19 Drug Discovery 87% Toxicity Prediction COPD + Asthma Models 35% CAGR Growth Air-Liquid Interface
Breathing Life Into Drug Development

LungChip

Microphysiological Pulmonary Systems

The lung-on-chip is the most validated organ-on-chip platform in existence. Used for COVID-19 drug discovery, COPD research, and respiratory toxicity testing. LungChip.com owns the definitive name in pulmonary microphysiology.

Acquire This Domain See Applications
AIR BLOOD O2 CO2
Clinical Applications

The Most Validated Organ Chip

Lung-on-chip technology leads the organ-on-chip revolution. From COVID-19 drug screening to chronic respiratory disease modeling, pulmonary chips have the strongest clinical validation.

COVID-19 Drug Discovery
During the pandemic, Emulate's Lung-Chip was used by researchers worldwide to screen potential COVID-19 therapeutics. The platform successfully identified amodiaquine and other compounds for clinical trials. FDA and NIH cited lung-chips as critical tools for rapid pandemic response.
$1.5B
OOC Market by 2030
35%
Annual growth rate
87%
Toxicity prediction accuracy
10x
Faster than animal trials
Research Areas

Pulmonary Use Cases

COPD Modeling
Chronic obstructive pulmonary disease research with human-relevant inflammation models.
Asthma Research
Airway hyperresponsiveness and bronchial inflammation studies for therapeutic development.
Inhaled Drug Testing
Aerosol deposition and pulmonary absorption studies at the air-liquid interface.
Pulmonary Fibrosis
IPF disease modeling and anti-fibrotic drug candidate screening.
Viral Infection
Influenza, RSV, and coronavirus infection modeling and therapeutic screening.
Lung Cancer
Tumor microenvironment modeling and immunotherapy response prediction.
Industry Leaders

Companies Building Lung Chips

Emulate
Market Leader
Pioneered the Lung-Chip. Used for COVID-19 research. FDA-validated platform.
AlveoliX
Breathing Lung
Cloud-ALI platform with mechanical breathing motion for realistic physiology.
MIMETAS
High-Throughput
OrganoPlate with bronchial and alveolar models in 96-well format.
Alveolix
Swiss Innovation
Breathing lung-on-chip with cyclic stretch mimicking respiration.
MatTek
Air-Liquid Interface
EpiAirway 3D tissue models for inhalation toxicology.
Epithelix
Airway Specialist
MucilAir reconstituted human airway epithelia for respiratory research.
LungChip.com

Own the Leader in Organ-on-Chip

The lung-on-chip is the most commercially successful organ chip platform. This domain captures that entire category.

Inquire About This Domain
Acquire This Domain

Own Lungchip

This premium domain is available for acquisition. Perfect for companies, startups, or investors in this space.

Submit your inquiry below and we'll respond within 24 hours.